CORT
CORCEPT THERAPEUTICS INC
+0.50 (+0.45%)112.31USD212K成交股數12.1B市值267.4本益比(近四季)14.6股價營收比+31.7%營收年增(近四季)2026-11-04下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 59 · 56.2M · 9 |
| 其中 10b5-1 計畫賣出 | 56 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 79.2M |
| 近 180 天 淨額 | −79.2M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-17 | WILSON JAMES N | Director | S 公開市場賣出(10b5-1) | 2.8K | 111.70 | 313K | 1.1M | SEC |
| 2026-09-15 | 09-17 | WILSON JAMES N | Director | S 公開市場賣出(10b5-1) | 6.8K | 110.27 | 750K | 1.1M | SEC |
| 2026-09-15 | 09-17 | WILSON JAMES N | Director | S 公開市場賣出(10b5-1) | 400 | 110.84 | 44K | 1.1M | SEC |
| 2026-09-14 | 09-17 | Lyon Joseph Douglas | See Remarks | S 公開市場賣出(10b5-1) | 2.2K | 114.12 | 250K | 5.7K | SEC |
| 2026-09-14 | 09-17 | Lyon Joseph Douglas | See Remarks | M 選擇權執行 | 7.4K | 13.56 | 100K | 15.7K | SEC |
| 2026-09-14 | 09-17 | Lyon Joseph Douglas | See Remarks | S 公開市場賣出(10b5-1) | 7.8K | 113.32 | 885K | 7.9K | SEC |
| 2026-09-14 | 09-17 | Lyon Joseph Douglas | See Remarks | M 選擇權執行 | 2.6K | 11.35 | 29K | 8.3K | SEC |
| 2026-09-02 | 09-03 | Mokari Atabak | Chief Financial Officer | F 繳稅扣股 | 102 | 113.38 | 12K | 16.3K | SEC |
| 2026-09-02 | 09-03 | Lyon Joseph Douglas | See Remarks | F 繳稅扣股 | 72 | 113.38 | 8K | 5.7K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | S 公開市場賣出(10b5-1) | 23.6K | 109.35 | 2.6M | 39.0K | SEC |
| 2026-09-02 | 09-03 | Robb Gary Charles | Chief Business Officer | F 繳稅扣股 | 91 | 113.38 | 10K | 13.7K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | S 公開市場賣出(10b5-1) | 23.8K | 110.70 | 2.6M | 15.2K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | F 繳稅扣股 | 102 | 113.38 | 12K | 4.2K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | M 選擇權執行 | 58.3K | 21.63 | 1.3M | 62.6K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | S 公開市場賣出(10b5-1) | 1.6K | 113.72 | 183K | 11.1K | SEC |
| 2026-09-02 | 09-03 | Maduck Sean | See Remarks | F 繳稅扣股 | 117 | 113.38 | 13K | 9.9K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | S 公開市場賣出(10b5-1) | 1.5K | 111.37 | 171K | 13.7K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | S 公開市場賣出(10b5-1) | 1.2K | 115.44 | 141K | 4.2K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | S 公開市場賣出(10b5-1) | 5.6K | 114.58 | 644K | 5.5K | SEC |
| 2026-09-02 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | S 公開市場賣出(10b5-1) | 974 | 112.40 | 109K | 12.7K | SEC |
| 2026-09-01 | 09-03 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 11.0K | 114.71 | 1.3M | 12.0K | SEC |
| 2026-09-01 | 09-03 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 11.7K | 113.94 | 1.3M | 23.0K | SEC |
| 2026-09-01 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | A 獲配股票 | 138 | – | – | 4.3K | SEC |
| 2026-09-01 | 09-03 | Maduck Sean | See Remarks | M 選擇權執行 | 25.0K | 8.27 | 207K | 34.8K | SEC |
| 2026-09-01 | 09-03 | Robb Gary Charles | Chief Business Officer | A 獲配股票 | 164 | – | – | 13.8K | SEC |
| 2026-09-01 | 09-03 | Vieira Roberto Wandenkolk | President, Oncology | A 獲配股票 | 138 | 113.38 | 16K | 4.2K | SEC |
| 2026-09-01 | 09-03 | Robb Gary Charles | Chief Business Officer | A 獲配股票 | 164 | 113.38 | 19K | 13.6K | SEC |
| 2026-09-01 | 09-03 | Lyon Joseph Douglas | See Remarks | A 獲配股票 | 130 | – | – | 5.8K | SEC |
| 2026-09-01 | 09-03 | Mokari Atabak | Chief Financial Officer | A 獲配股票 | 138 | – | – | 16.4K | SEC |
| 2026-09-01 | 09-03 | Lyon Joseph Douglas | See Remarks | A 獲配股票 | 130 | 113.38 | 15K | 5.6K | SEC |
| 2026-09-01 | 09-03 | Maduck Sean | See Remarks | A 獲配股票 | 150 | – | – | 10.1K | SEC |
| 2026-09-01 | 09-03 | Guyer William | Chief Development Officer | A 獲配股票 | 164 | 113.38 | 19K | 4.1K | SEC |
| 2026-09-01 | 09-03 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 2.3K | 115.61 | 264K | 9.8K | SEC |
| 2026-09-01 | 09-03 | Guyer William | Chief Development Officer | A 獲配股票 | 164 | – | – | 4.3K | SEC |
| 2026-09-01 | 09-03 | Maduck Sean | See Remarks | A 獲配股票 | 150 | 113.38 | 17K | 9.9K | SEC |
| 2026-09-01 | 09-03 | Mokari Atabak | Chief Financial Officer | A 獲配股票 | 138 | 113.38 | 16K | 16.3K | SEC |
| 2026-08-26 | 08-28 | Park Kimberly | Director | F 繳稅扣股 | 3.3K | 122.09 | 405K | 26.7K | SEC |
| 2026-08-26 | 08-28 | Park Kimberly | Director | M 選擇權執行 | 30.0K | 13.49 | 405K | 30.0K | SEC |
| 2026-08-26 | 08-28 | Park Kimberly | Director | S 公開市場賣出 | 26.7K | 122.55 | 3.3M | 0 | SEC |
| 2026-08-25 | 08-27 | Maduck Sean | See Remarks | M 選擇權執行 | 31.0K | 11.35 | 351K | 40.7K | SEC |
| 2026-08-25 | 08-27 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 25.1K | 125.47 | 3.1M | 15.6K | SEC |
| 2026-08-25 | 08-27 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 5.9K | 126.06 | 740K | 9.8K | SEC |
| 2026-08-18 | 08-20 | MAHONEY DAVID L | Director | S 公開市場賣出(10b5-1) | 400 | 119.64 | 48K | 1.1M | SEC |
| 2026-08-18 | 08-20 | MAHONEY DAVID L | Director | S 公開市場賣出(10b5-1) | 7.1K | 118.88 | 839K | 1.1M | SEC |
| 2026-08-18 | 08-20 | MAHONEY DAVID L | Director | S 公開市場賣出(10b5-1) | 91.2K | 118.24 | 10.8M | 1.1M | SEC |
| 2026-08-18 | 08-20 | MAHONEY DAVID L | Director | S 公開市場賣出(10b5-1) | 5.0K | 117.47 | 585K | 1.2M | SEC |
| 2026-08-17 | 08-18 | Robb Gary Charles | Chief Business Officer | S 公開市場賣出 | 10.0K | 116.26 | 1.2M | 39.7K | SEC |
| 2026-08-17 | 08-18 | Robb Gary Charles | Chief Business Officer | G 贈與 | 125 | – | – | 13.4K | SEC |
| 2026-08-14 | 08-18 | WILSON JAMES N | Director | S 公開市場賣出(10b5-1) | 3.1K | 110.49 | 337K | 1.1M | SEC |
| 2026-08-14 | 08-18 | WILSON JAMES N | Director | S 公開市場賣出(10b5-1) | 2.3K | 112.64 | 257K | 1.1M | SEC |
| 2026-08-14 | 08-18 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 3.7K | 114.49 | 419K | 9.8K | SEC |
| 2026-08-14 | 08-18 | Maduck Sean | See Remarks | M 選擇權執行 | 3.7K | 8.27 | 30K | 13.4K | SEC |
| 2026-08-14 | 08-18 | WILSON JAMES N | Director | S 公開市場賣出(10b5-1) | 4.7K | 111.44 | 520K | 1.1M | SEC |
| 2026-08-12 | 08-14 | Robb Gary Charles | Chief Business Officer | G 贈與 | 3.0K | – | – | 15.6K | SEC |
| 2026-08-12 | 08-14 | Robb Gary Charles | Chief Business Officer | G 贈與 | 11.5K | – | – | 13.6K | SEC |
| 2026-08-10 | 08-12 | Guyer William | Chief Development Officer | S 公開市場賣出(10b5-1) | 11.5K | 113.18 | 1.3M | 8.8K | SEC |
| 2026-08-10 | 08-12 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 1.0K | 114.52 | 118K | 9.8K | SEC |
| 2026-08-10 | 08-12 | Guyer William | Chief Development Officer | M 選擇權執行 | 16.3K | 21.65 | 353K | 20.3K | SEC |
| 2026-08-10 | 08-12 | Maduck Sean | See Remarks | M 選擇權執行 | 1.0K | 8.27 | 9K | 10.8K | SEC |
| 2026-08-10 | 08-12 | Guyer William | Chief Development Officer | S 公開市場賣出(10b5-1) | 4.8K | 114.04 | 544K | 4.0K | SEC |
| 2026-08-04 | 08-06 | Guyer William | Chief Development Officer | S 公開市場賣出(10b5-1) | 3.7K | 113.12 | 419K | 4.0K | SEC |
| 2026-08-04 | 08-06 | Guyer William | Chief Development Officer | M 選擇權執行 | 3.7K | 21.65 | 80K | 7.7K | SEC |
| 2026-08-03 | 08-05 | Lyon Joseph Douglas | See Remarks | S 公開市場賣出 | 1.5K | 114.16 | 176K | 5.5K | SEC |
| 2026-08-03 | 08-05 | Maduck Sean | See Remarks | M 選擇權執行 | 20.3K | 8.27 | 168K | 30.1K | SEC |
| 2026-08-03 | 08-05 | Maduck Sean | See Remarks | S 公開市場賣出(10b5-1) | 20.3K | 114.70 | 2.3M | 9.8K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.2K | 105.54 | 443K | 91.9K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 8.1K | 119.95 | 972K | 17.1K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.8K | 118.73 | 568K | 25.2K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 8.3K | 117.93 | 975K | 30.0K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 7.1K | 116.96 | 829K | 38.3K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 14.2K | 115.87 | 1.6M | 45.4K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 15.5K | 114.96 | 1.8M | 59.6K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 113.18 | 532K | 75.1K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 600 | 110.95 | 67K | 79.8K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.2K | 110.03 | 242K | 80.4K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 400 | 108.46 | 43K | 82.6K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 9.0K | 106.96 | 958K | 83.0K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.0K | 120.67 | 121K | 16.1K | SEC |
| 2026-07-30 | 08-03 | Mokari Atabak | Chief Financial Officer | M 選擇權執行 | 80.0K | 23.06 | 1.8M | 96.1K | SEC |
| 2026-07-15 | 07-17 | Mokari Atabak | Chief Financial Officer | M 選擇權執行 | 15.8K | 19.26 | 305K | 32.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 12.4M | 1.1B | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 5.3M | 457M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | 439M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | 363M | 新進 | 新進 |
| Parallel Advisors, LLC | 4.0M | 345M | 新進 | 新進 |
| FMR LLC | 3.3M | 290M | 新進 | 新進 |
| STATE STREET CORP | 3.3M | 285M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 2.6M | 225M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5M | 220M | 新進 | 新進 |
| FIRST TRUST ADVISORS LP | 1.8M | 159M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 1.5M | 130M | 新進 | 新進 |
| UBS Group AG | 1.4M | 120M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.3M | 115M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | 101M | 新進 | 新進 |
| MORGAN STANLEY | 1.1M | 98.9M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 883K | 76.8M | 新進 | 新進 |
| Cerity Partners LLC | 797K | 69.3M | 新進 | 新進 |
| MPM BIOIMPACT LLC | 771K | 67.0M | 新進 | 新進 |
| NORTHERN TRUST CORP | 754K | 65.5M | 新進 | 新進 |
| EMERALD ADVISERS, LLC | 748K | 65.1M | 新進 | 新進 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 710K | 61.7M | 新進 | 新進 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 696K | 60.5M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 614K | 53.4M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 610K | 53.0M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 569K | 49.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 423 +71 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 423 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 82.4M · 76.2% |
| 合計季末市值 | 6.4B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 9.4M |
|---|---|
| 與上期比 | -3.1% |
| 佔流通股數 | 8.69% |
| 日均成交量 | 790K |
| 回補天數 | 11.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 9.4M | -3.1% | 8.69% | 790K | 11.9 |
| 2026-08-14 | 9.7M | -1.3% | 8.97% | 928K | 10.5 |
| 2026-07-31 | 9.8M | +4.0% | 9.08% | 1.5M | 6.4 |
| 2026-07-15 | 9.4M | +9.3% | 8.74% | 1.1M | 8.7 |
| 2026-06-30 | 8.6M | +0.8% | 7.99% | 1.0M | 8.4 |
| 2026-06-15 | 8.6M | -2.5% | 7.93% | 969K | 8.8 |
| 2026-05-29 | 8.8M | -5.6% | 8.13% | 1.0M | 8.6 |
| 2026-05-15 | 9.3M | -13.0% | 8.62% | 1.5M | 6.3 |
| 2026-04-30 | 10.7M | -5.6% | 9.91% | 932K | 11.5 |
| 2026-04-15 | 11.3M | -8.9% | 10.49% | 1.2M | 9.7 |
| 2026-03-31 | 12.4M | -4.4% | 11.52% | 2.5M | 5.0 |
| 2026-03-13 | 13.0M | +4.5% | 12.05% | 1.2M | 11.2 |
| 2026-02-27 | 12.5M | +24.1% | 11.53% | 2.6M | 4.8 |
| 2026-02-13 | 10.0M | +8.3% | 9.29% | 1.2M | 8.4 |
| 2026-01-30 | 9.3M | +13.3% | 8.58% | 2.7M | 3.5 |
| 2026-01-15 | 8.2M | -10.5% | 7.57% | 2.6M | 3.2 |
| 2025-12-31 | 9.1M | -9.5% | 8.46% | 3.0M | 3.0 |
| 2025-12-15 | 10.1M | -2.3% | 9.35% | 875K | 11.6 |
| 2025-11-28 | 10.3M | +1.7% | 9.57% | 523K | 19.8 |
| 2025-11-14 | 10.2M | -8.0% | 9.41% | 730K | 13.9 |
| 2025-10-31 | 11.0M | +7.9% | 10.22% | 779K | 14.2 |
| 2025-10-15 | 10.2M | -3.8% | 9.47% | 1.0M | 9.8 |
| 2025-09-30 | 10.6M | -1.5% | 9.85% | 1.1M | 10.0 |
| 2025-09-15 | 10.8M | -0.7% | 10.00% | 685K | 15.8 |
| 2025-08-29 | 10.9M | +2.8% | 10.07% | 622K | 17.5 |
| 2025-08-15 | 10.6M | -4.1% | 9.80% | 891K | 11.9 |